Jiayi Li

Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.

B. Peng, Lei Yang, Y. Bai, 2023, JAMA.

Pembrolizumab in patients from China with microsatellite instability-high/mismatch repair deficient tumors: KEYNOTE-158.

Yi Huang, Jianming Xu, X. Yin, 2024, Immunotherapy.

A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol

Ying Cheng, E. Li, Yanqiao Zhang, 2023, Technology in cancer research & treatment.